These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 22201475)

  • 21. Assessment of a new instrument for detecting preventable adverse drug reactions.
    Benkirane R; Soulaymani-Bencheikh R; Khattabi A; Benabdallah G; Alj L; Sefiani H; Hedna K; Ouammi L; Olsson S; Pal SN
    Drug Saf; 2015 Apr; 38(4):383-93. PubMed ID: 25537235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention.
    Hug BL; Witkowski DJ; Sox CM; Keohane CA; Seger DL; Yoon C; Matheny ME; Bates DW
    J Gen Intern Med; 2010 Jan; 25(1):31-8. PubMed ID: 19894081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study.
    Lo Giudice I; Mocciaro E; Giardina C; Barbieri MA; Cicala G; Gioffrè-Florio M; Carpinteri G; Di Grande A; Spina E; Arcoraci V; Cutroneo PM
    BMC Pharmacol Toxicol; 2019 Apr; 20(1):21. PubMed ID: 31029178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis.
    Kunac DL; Tatley MV
    Drug Saf; 2011 Jan; 34(1):59-71. PubMed ID: 21142271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and Initial Validation of a Patient-Reported Adverse Drug Event Questionnaire.
    de Vries ST; Mol PG; de Zeeuw D; Haaijer-Ruskamp FM; Denig P
    Drug Saf; 2013 Sep; 36(9):765-77. PubMed ID: 23553447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving drug safety in hospitals: a retrospective study on the potential of adverse drug events coded in routine data.
    Kuklik N; Stausberg J; Amiri M; Jöckel KH
    BMC Health Serv Res; 2019 Aug; 19(1):555. PubMed ID: 31395053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for hospital admissions associated with adverse drug events.
    Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM
    Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.
    Bates DW; Cullen DJ; Laird N; Petersen LA; Small SD; Servi D; Laffel G; Sweitzer BJ; Shea BF; Hallisey R
    JAMA; 1995 Jul; 274(1):29-34. PubMed ID: 7791255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring the preventability of adverse drug reactions in France: A 2015 overview.
    Olivier-Abbal P
    Therapie; 2016 Apr; 71(2):195-202. PubMed ID: 27080838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying drug safety issues: from research to practice.
    Gandhi TK; Seger DL; Bates DW
    Int J Qual Health Care; 2000 Feb; 12(1):69-76. PubMed ID: 10733086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and Preventability of Medication Errors and ADEs in Ambulatory Care Older Patients.
    Díaz Hernández SH; Cruz-Gonzalez I
    Consult Pharm; 2018 Aug; 33(8):454-466. PubMed ID: 30068439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ambulatory Computerized Prescribing and Preventable Adverse Drug Events.
    Overhage JM; Gandhi TK; Hope C; Seger AC; Murray MD; Orav EJ; Bates DW
    J Patient Saf; 2016 Jun; 12(2):69-74. PubMed ID: 26001546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.
    Carnevali L; Krug B; Amant F; Van Pee D; Gérard V; de Béthune X; Spinewine A
    Ann Pharmacother; 2013 Nov; 47(11):1414-9. PubMed ID: 24285758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of medication-related adverse events in inpatients-a systematic review and meta-analysis.
    Laatikainen O; Miettunen J; Sneck S; Lehtiniemi H; Tenhunen O; Turpeinen M
    Eur J Clin Pharmacol; 2017 Dec; 73(12):1539-1549. PubMed ID: 28871436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Practical approach to determining costs and frequency of adverse drug events in a health care network.
    Senst BL; Achusim LE; Genest RP; Cosentino LA; Ford CC; Little JA; Raybon SJ; Bates DW
    Am J Health Syst Pharm; 2001 Jun; 58(12):1126-32. PubMed ID: 11449856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential Direct Costs of Adverse Drug Events and Possible Cost Savings Achievable by their Prevention in Tuscany, Italy: A Model-Based Analysis.
    Convertino I; Salvadori S; Pecori A; Galiulo MT; Ferraro S; Parrilli M; Corona T; Turchetti G; Blandizzi C; Tuccori M
    Drug Saf; 2019 Mar; 42(3):427-444. PubMed ID: 30276630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic structured interviews in child and adolescent's psychiatry].
    Renou S; Hergueta T; Flament M; Mouren-Simeoni MC; Lecrubier Y
    Encephale; 2004; 30(2):122-34. PubMed ID: 15107714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliability evaluation of the adapted national coordinating council medication error reporting and prevention (NCC MERP) index.
    Snyder RA; Abarca J; Meza JL; Rothschild JM; Rizos A; Bates DW
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):1006-13. PubMed ID: 17523185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Psychometric characteristics of questionnaires designed to assess the knowledge, perceptions and practices of health care professionals with regards to alcoholic patients].
    Jaussent S; Labarère J; Boyer JP; François P
    Encephale; 2004; 30(5):437-46. PubMed ID: 15627048
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.